ulbi20230726c

0001437749-23-020793.txt : 20230727 0001437749-23-020793.hdr.sgml : 20230727 20230727073029 ACCESSION NUMBER: 0001437749-23-020793 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230727 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 231115308 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 ulbi20230726c_8k.htm FORM 8-K ulbi20230726c_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


July 27, 2023
Date of Report (Date of Earliest Event Reported)


ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)

Delaware	000-20852	16-1387013
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)

(315) 332-7100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Common Stock, $0.10 par value per share	ULBI	NASDAQ
(Title of each class)	(Trading Symbol)	(Name of each exchange on which registered)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On July 27, 2023, Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.

Item 9.01 Financial Statements, Pro Forma Financials and Exhibits

(d) Exhibits.

Exhibit Number		Exhibit Description
99.1		Press Release of Ultralife Corporation dated July 27, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 27, 2023		ULTRALIFE CORPORATION


	By:	/s/ Philip A. Fain
		Philip A. Fain
		Chief Financial Officer and Treasurer

EX-99.1 2 ex_548759.htm EXHIBIT 99.1 ex_548759.htm

Exhibit 99.1

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y. – July 27, 2023 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights:

●

Sales of $42.7 million representing a 32.9% year-over-year increase

●

Operating income of $3.7 million compared to $0.8 million for the 2022 second quarter

●

Adjusted EPS of $0.29 compared to $0.03 for the 2022 second quarter

●

Adjusted EBITDA of $6.3 million or 14.7% of sales versus $2.2 million or 6.8% last year

●

Backlog increase to $110.9 million, the highest level in the Company’s history

“Driven by surging demand from our government/defense and medical customers, we delivered a 33% year-over-year sales increase to $42.7 million for the second quarter. Leveraged by a sequential improvement in gross margin and disciplined spending, operating profit more than quadrupled from the year-earlier quarter to $3.7 million, the highest level since the third quarter of 2010. With backlog increasing to $110.9 million and durable demand across our diverse end markets, the near-term highest priority remains to recapture gross margin through continued execution of price realization activities, qualification of alternate component suppliers, and lean manufacturing initiatives,” said Mike Manna, President and Chief Executive Officer. “These actions position us to deliver high-quality, sustainable profitable growth for 2023 generating incremental cash flow to pay down our acquisition debt and further invest in our businesses. We continue to strengthen our relationships with our key customers using our global new product development and sales resources to support future growth in target markets.”

Second Quarter 2023 Financial Results

Revenue was $42.7 million, an increase of $10.6 million, or 32.9%, as compared to revenue of $32.1 million for the second quarter of 2022. Overall, government/defense sales increased 111.5% and commercial sales increased 9.2% over the 2022 period. Battery & Energy Products sales increased 12.3% to $33.9 million, compared to $30.1 million last year, reflecting increases of 26.6% in government/defense sales, 25.2% in medical battery sales, and 17.9% in oil & gas market sales, partially offset by an 18.8% decrease in other commercial sales. Communications Systems sales increased more than four-fold to $8.8 million compared to $2.0 million for the same period last year, primarily attributable to shipments of vehicle-amplifier adaptors to a global defense contractor for the U.S. Army and of integrated systems of amplifiers and radio vehicle mounts to a major international defense contractor under an ongoing allied country government/defense modernization program. Our total backlog exiting the second quarter was $110.9 million representing a 40.1% increase over the comparable period last year with $76.4 million of the total backlog due to ship over the remaining six months of 2023. Total backlog increased $2.8 million or 2.6% compared to the backlog exiting the first quarter.

Gross profit was $10.6 million, or 24.8% of revenue, compared to $7.6 million, or 23.8% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 22.3%, compared to 23.7% last year, primarily due to lingering inefficiencies resulting from the first quarter cyber-attack, disposition of certain non-conforming materials and continued investments in the transition of new products to high volume production, partially offset by improved price realization. Communications Systems gross margin was 34.5% compared to 24.9% last year, primarily due to higher factory volume and favorable product mix.

Operating expenses were $6.9 million, the same as that reported for the 2022 second quarter. Operating expenses were 16.2% of revenue compared to 21.3% of revenue for the year-earlier period.

The combination of higher gross profit and flat operating expenses resulted in a $2.9 million increase in operating income to $3.7 million from $0.8 million last year.

Other income, reported below operating income, includes an Employee Retention Credit (“ERC”) for $1.5 million under Section 2301 of the Coronavirus Aid, Relief and Economic Security Act of 2020 and the American Rescue Plan of 2021 which was filed with the Internal Revenue Service during the second quarter of 2023.

Net income was $3.3 million or $0.21 per diluted share on a GAAP basis, compared to net income of $0.5 million or $0.03 per diluted share for the second quarter of 2022. Adjusted EPS was $0.29 on a diluted basis for the second quarter of 2023, compared to $0.03 for the 2022 period. Adjusted EPS excludes the provision for deferred taxes of $1.3 million which primarily represents non-cash charges for U.S. taxes which will be fully offset by net operating loss carryforwards and other tax credits for the foreseeable future.

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense, was $6.3 million for the second quarter of 2023, or 14.7% of sales, including the ERC, compared to $2.2 million, or 6.8% of sales, for the year-earlier period.

See the “Non-GAAP Financial Measures” section of this release for a reconciliation of adjusted EPS to EPS and adjusted EBITDA to net income attributable to Ultralife Corporation.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

Conference Call Information

Ultralife will hold its second quarter earnings conference call today at 8:30 AM ET.

To ensure a fast and reliable connection to our investor conference call, we now require participants dialing in by phone to register using the following link prior to the call: https://register.vevent.com/register/BI05d612e50dae4c4f91cf91687da98603. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include the impact of COVID-19 and related supply chain disruptions, potential reductions in revenues from key customers, acceptance of our new products on a global basis and uncertain global economic conditions. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

ASSETS

	June 30,			December 31,
	2023			2022
Current Assets:
Cash	$	8,283		$	5,713
Trade Accounts Receivable, Net		28,630			27,779
Inventories, Net		46,063			41,192
Prepaid Expenses and Other Current Assets		4,850			4,304
Total Current Assets		87,826			78,988

Property, Plant and Equipment, Net		21,122			21,716
Goodwill		37,501			37,428
Other Intangible Assets, Net		15,552			15,921
Deferred Income Taxes, Net		11,084			12,069
Other Non-Current Assets		2,307			2,308

Total Assets	$	175,392		$	168,430



LIABILITIES AND SHAREHOLDERS' EQUITY


Current Liabilities:
Accounts Payable	$	18,541		$	16,074
Current Portion of Long-Term Debt		2,000			2,000
Accrued Compensation and Related Benefits		2,320			2,890
Accrued Expenses and Other Current Liabilities		6,342			7,949
Total Current Liabilities		29,203			28,913
Long-Term Debt, Net		22,642			19,310
Deferred Income Taxes		1,876			1,917
Other Non-Current Liabilities		1,996			1,887
Total Liabilities		55,717			52,027

Shareholders' Equity:
Common Stock		2,059			2,057
Capital in Excess of Par Value		187,758			187,405
Accumulated Deficit		(44,957	)		(47,951	)
Accumulated Other Comprehensive Loss		(3,846	)		(3,750	)
Treasury Stock		(21,484	)		(21,484	)
Total Ultralife Equity		119,530			116,277
Non-Controlling Interest		145			126
Total Shareholders’ Equity		119,675			116,403

Total Liabilities and Shareholders' Equity	$	175,392		$	168,430

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)

(Unaudited)

	Three-Month Period Ended					Six-Month Period Ended
	June 30,		June 30,			June 30,		June 30,
	2023		2022			2023		2022
Revenues:
Battery & Energy Products	$	33,861	$	30,140		$	62,331	$	59,290
Communications Systems		8,831		1,986			12,277		3,209
Total Revenues		42,692		32,126			74,608		62,499

Cost of Products Sold:
Battery & Energy Products		26,318		22,989			48,276		45,418
Communications Systems		5,786		1,491			8,308		2,477
Total Cost of Products Sold		32,104		24,480			56,584		47,895

Gross Profit		10,588		7,646			18,024		14,604

Operating Expenses:
Research and Development		1,778		1,672			3,810		3,529
Selling, General and Administrative		5,145		5,181			10,523		10,577
Total Operating Expenses		6,923		6,853			14,333		14,106

Operating Income		3,665		793			3,691		498

Other Income (Expense)		1,058		(115	)		564		(232	)
Income Before Income Taxes		4,723		678			4,255		266

Income Tax Provision (Benefit)		1,375		170			1,242		(81	)

Net Income		3,348		508			3,013		347

Net Income (Loss) Income Attributable to Non-Controlling Interest		8		(4	)		19		3

Net Income Attributable to Ultralife Corporation	$	3,340	$	512		$	2,994	$	344

Net Income Per Share Attributable to Ultralife Common Shareholders – Basic	$	.21	$	.03		$	.19	$	.02

Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted	$	.21	$	.03		$	.19	$	.02

Weighted Average Shares Outstanding – Basic		16,141		16,129			16,138		16,116

Weighted Average Shares Outstanding – Diluted		16,144		16,149			16,141		16,141

Non-GAAP Financial Measures

Adjusted EBITDA

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision (benefit) for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

	Three-Month Period Ended				Six-Month Period Ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022

Net Income Attributable to Ultralife Corporation	$	3,340	$	512	$	2,994	$	344
Adjustments:
Interest Expense, Net		440		177		864		311
Income Tax Provision (Benefit)		1,375		170		1,242		(81	)
Depreciation Expense		760		819		1,522		1,635
Amortization Expense		227		323		436		651
Stock-Based Compensation Expense		154		184		293		373
Cyber-Insurance Policy Deductible		-		-		100		-
Non-Cash Purchase Accounting Adjustment		-		-		-		55
Adjusted EBITDA	$	6,296	$	2,185	$	7,451	$	3,288

Adjusted Earnings Per Share

In evaluating our business, we consider and use adjusted EPS, a non-GAAP financial measure, as a supplemental measure of our business performance. We define adjusted EPS as net income attributable to Ultralife Corporation excluding the provision (benefit) for deferred income taxes divided by our weighted average shares outstanding on both a basic and diluted basis. We believe that this information is useful in providing period-to-period comparisons of our results by reflecting the portion of our tax provision that will be predominantly offset by our U.S. net operating loss carryforwards and other tax credits for the foreseeable future. We reconcile adjusted EPS to EPS, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EPS as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EPS to EPS and net income attributable to Ultralife Corporation.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EPS

(In Thousands Except Per Share Amounts)

(Unaudited)

	Three-Month Period Ended
	June 30, 2023						June 30, 2022
	Amount		Per Basic Share		Per Diluted Share		Amount		Per Basic Share		Per Diluted Share
Net Income	$	3,340	$	.21	$	.21	$	512	$	.03	$	.03
Deferred Tax Provision		1,278		.08		.08		27		-		-
Adjusted Net Income	$	4,618	$	.29	$	.29	$	539	$	.03	$	.03

Weighted Average Shares Outstanding				16,141		16,144				16,129		16,149

	Six-Month Period Ended
	June 30, 2023						June 30, 2022
	Amount		Per Basic Share		Per Diluted Share		Amount			Per Basic Share			Per Diluted Share
Net Income	$	2,994	$	.19	$	.19	$	344		$	.02		$	.02
Deferred Tax Provision (Benefit)		888		.05		.05		(375	)		(.02	)		(.02	)
Adjusted Net Income (Loss)	$	3,882	$	.24	$	.24	$	(31	)	$	.00		$	.00

Weighted Average Shares Outstanding				16,138		16,141					16,116			16,141

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

Investor Relations Contact:

LHA

Jody Burfening

(212) 838-3777

jburfening@lhai.com

EX-101.SCH 3 ulbi-20230727.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ulbi-20230727_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ulbi-20230727_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 ulbi-20230727_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 ex_548759img001.jpg begin 644 ex_548759img001.jpg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htm IDEA: XBRL DOCUMENT

Document And Entity Information	Jul. 27, 2023
Document Information [Line Items]
Entity, Registrant Name	ULTRALIFE CORPORATION
Document, Type	8-K
Document, Period End Date	Jul. 27, 2023
Entity, Incorporation, State or Country Code	DE
Entity, File Number	000-20852
Entity, Tax Identification Number	16-1387013
Entity, Address, Address Line One	2000 Technology Parkway
Entity, Address, City or Town	Newark
Entity, Address, State or Province	NY
Entity, Address, Postal Zip Code	14513
City Area Code	315
Local Phone Number	332-7100
Title of 12(b) Security	Common Stock
Trading Symbol	ULBI
Security Exchange Name	NASDAQ
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity, Emerging Growth Company	false
Amendment Flag	false
Entity, Central Index Key	0000875657

XML 9 ulbi20230726c_8k_htm.xml IDEA: XBRL DOCUMENT 0000875657 2023-07-27 2023-07-27 false 0000875657 8-K 2023-07-27 ULTRALIFE CORPORATION DE 000-20852 16-1387013 2000 Technology Parkway Newark NY 14513 315 332-7100 Common Stock ULBI NASDAQ false false false false false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ulbi.com/20230727/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ulbi20230726c_8k.htm ex_548759.htm ulbi-20230727.xsd ulbi-20230727_def.xml ulbi-20230727_lab.xml ulbi-20230727_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ulbi20230726c_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "contextCount": 1, "dts": { "definitionLink": { "local": [ "ulbi-20230727_def.xml" ] }, "inline": { "local": [ "ulbi20230726c_8k.htm" ] }, "labelLink": { "local": [ "ulbi-20230727_lab.xml" ] }, "presentationLink": { "local": [ "ulbi-20230727_pre.xml" ] }, "schema": { "local": [ "ulbi-20230727.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ulbi", "nsuri": "http://www.ulbi.com/20230727", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ulbi20230726c_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.ulbi.com/20230727/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ulbi20230726c_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.ulbi.com/20230727/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001437749-23-020793-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-020793-xbrl.zip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end